期刊文献+

半边莲生物碱对高血压鼠脑基底动脉血管平滑肌细胞增殖的影响 被引量:4

Effect of lobelia chinensis lour alkaloids on smooth muscle cell proliferation of cerebral basilar artery in hypertensive rat
在线阅读 下载PDF
导出
摘要 目的:观察半边莲生物碱对高血压鼠脑基底动脉血管平滑肌细胞增殖的作用.方法:分别使用50、100和150mg/L不同剂量半边莲生物碱孵育高血压鼠脑基底动脉平滑肌细胞,以细胞计数试剂盒计数各组细胞个数、[3H]-TdR掺入检测各组DNA的合成量作为细胞增殖的指标.结果:各组细胞数量下降;各组血管平滑肌细胞DNA的合成量均下降,以100mg/L组下降最为明显.结论:半边莲生物碱可抑制高血压所诱导的脑基底动脉血管平滑肌细胞增殖,提示半边莲生物碱可用于高血压诱发的脑血管重构. Objective: To investigate the erfects of lobeIia chinensis lour alkaloids (LCLA) on smooth muscle cell proliferation of cerebral basilar artery in hypertensive rats. Methods: The smooth muscle cells of the cerebral basilar artery in hypertensive rats were incubated by 50, 100 and 150 mg/L LCLA in each group. Then, to observe the cell proliferation in each group, the cell number was quantified by cell counting kit and DNA synthesis was measured by ^3H-TdR incorporation. Resuits: Compared with the control group, the cell number of each group was markedly declined; DNA synthesis of smooth muscle cells in each group was obviously descended. The drop of 100 mg/L group was most famous among three groups. Conclusion : LCLA may significantly inhibit the hypertension-induced proliferation of smooth muscle cells in the cerebral basilar artery, suggesting that LCLA may prevent and treat hypertension-induced cerebrovascular remodeling.
出处 《解剖学杂志》 CAS CSCD 北大核心 2011年第2期188-190,共3页 Chinese Journal of Anatomy
基金 江西省自然科学基金项目(2009GZY0134) 江西省教育厅科技资助项目(赣教技字E2007180号)
关键词 脑血管 平滑肌细胞 半边莲生物碱 高血压 cerebral blood vessel smooth muscle cell lobelia chinensis lour alkaloid hypertension
  • 相关文献

参考文献9

  • 1Touyz R M.Intracellular mechanisms involved in vascular remodeling of resistance arteries in hypertension:role of angiotensin II[J].Exp Physiol,2005,90(4):449-455.
  • 2Aukes A M,Vitullo L,Zeeman G G,et al.Pregnancy prevents hypertensive remodeling and decreases myogenic reactivity in posterior cerebral arteries from Dahl salt-sensitive rats:a role in eclampsia[J].Am J Physiol Heart Circ Physiol,2007,292(2):H1071-H1076.
  • 3Schmieder R E.Hypertensive retinopathy:a window to vascular remodeling in arterial hypertension[J].Hypertension,2008,51(1):43-44.
  • 4Harazny J M,Ritt M,Baleanu D,et al.Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event[J].Hypertension,2007,50(4):623-629.
  • 5Jimenz-Altayo F,Martin A,Rojas S,et al.Transient middle cerebral artery occlusion causes different structural,mechanical,and myogenic alterations in normotensive and hypertensive rats[J].Am J Physiol Heart Circ Physiol,2007,293(1):H628-H635.
  • 6Li L,Zhu D L,Shen W L,et al.Increased migration of vascular adventitial fibroblasts from spontaneously hypertensive rats[J].Hypertens Res,2006,29(2):95-103.
  • 7Hou Y Z,Yang J,Zhao G R,et al.Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotinsion Ⅱ[J].Eur J Pharmacol,2004,499(1-20):85-90.
  • 8张晓玲,薛冰,李莉,陈融,任冬梅,李瑞峰,胡维诚.半边莲生物碱抑制肾性高血压大鼠内皮素1 mRNA和蛋白表达[J].中国动脉硬化杂志,2007,15(1):11-14. 被引量:6
  • 9Sabbatini M,Strocchi P,Vitaioli L,et al.Microanatomical changes of intracerebral arteries in spontaneously hypertensive rats:a model of cerebrovascular disease of the elderly[J].Mech Ageing Dev,2001,122(12):1257-1268.

二级参考文献11

  • 1吴秀香,马克玲,李淑云,王国秋,庄晓艳.内皮素、降钙素基因相关肽在肾性高血压大鼠的动态变化[J].中国心血管杂志,2005,10(3):180-182. 被引量:2
  • 2王婧婧,范秀珍,刘尚明,魏欣冰,任冬梅,陈融,李莉,胡维诚.半边莲生物碱抑制内皮素诱导的大鼠主动脉平滑肌细胞增殖[J].中国动脉硬化杂志,2006,14(2):107-110. 被引量:7
  • 3Quaschning T,Hocher B,Ruhl S,Kraemer-Guth A,Tilgner J,Wanner C,et al.Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension[J].Kidney Blood Press Res,2006,29 (6):351-359.
  • 4Rajagopalan S,Laursen JB,Borthayre A,Kurz S,Keiser J,Haleen S,et a1.Role for endothelin-1 in angiotensin Ⅱ mediated hypertension[J].Hypertension,1997,30 (pt1):29-34.
  • 5Sokolovsky M.Structure-function relationships of endothelins,sarafotoxins,and their receptor subtypes[J].J Neurochem,1992,59 (3):809-821.
  • 6Ducancel F,Matre V,Dupont C,Lajeunesse E,Wollberg Z,Bdolah A,et al.Cloning and sequence analysis of cDNAs encoding precursors of sarafotoxins.Evidence for an unusual "rosary-type" organization[J].J Biological Chemistry,1993,268 (5):3 052-055.
  • 7Pollock DM,Keith TL,Highsmith RF.Endothelin receptor and calcium signaling[J].FASEB J,1995,9:1 196-204.
  • 8Prieto I,Hermoso F,Gasparo M,Vargas F,Alba F,Segarra AB,et al.Angiotensinase activities in the kidney of renovascular hypertensive rats[J].Peptides,2003,24 (5):755-760.
  • 9杜艳芝,闫晓梅,胡维诚,刘玉梅,张宝华,李莉,陈融,刘建伟.清热解毒液对高脂血症大鼠内皮素影响的研究[J].中国病理生理杂志,1999,15(12):1134-1137. 被引量:30
  • 10李瑞峰,郭成浩,陈融,李莉,孔乐凯,王建丽,胡维诚.链脲佐菌素诱导的糖尿病大鼠外周血白细胞iNOS-mRNA表达的变化[J].中国病理生理杂志,2001,17(12):1240-1242. 被引量:12

共引文献5

同被引文献23

  • 1王婧婧,范秀珍,刘尚明,任冬梅,陈融,李莉,胡维诚.半边莲生物碱抑制内皮素-1诱导的人脐动脉平滑肌细胞增殖[J].中国病理生理杂志,2006,22(1):26-30. 被引量:7
  • 2王婧婧,范秀珍,刘尚明,魏欣冰,任冬梅,陈融,李莉,胡维诚.半边莲生物碱抑制内皮素诱导的大鼠主动脉平滑肌细胞增殖[J].中国动脉硬化杂志,2006,14(2):107-110. 被引量:7
  • 3Onat A M, Pehlivan Y,Turkbeyler I H, et al. Urotensin inhib- ition with palosuran could be a promising alternative in pulmo- nary arterial hypertension [J]. Inflammation,2013,36 (2):405- 12.
  • 4Wort S J,Woods M,Warner T D,et al. Endogenously released endothelin-1 from human pulmonary artery smooth muscle pro- motes cellular proliferation:relevance to pathogenesis of pul- monary hypertension and vascular remodeling[J]. Am J Respir Cell Mol Biol,2001,25(1 ) : 104-10.
  • 5Seferian A,Simonneau G. Therapies for pulmonary arterial hyp- ertension:where are we today,where do we go tomorrow[J]. Eur Respir Rev, 2013,22 (129) : 217-26.
  • 6Raja S G. Endothelin receptor antagonists for pulmonary arterial hypertension:an over-view [J]. Cardiovasc Ther,2010,28 (5): e65-e71.
  • 7Lim K A,Kim K C,Cho M S,et al. Gene expression of endothe- lin-1 and endothelin receptor a on monocrotaline induced pul- monary hypertension in rats after bosentan treatment[J]. Korean Circ J,2010,40(9):459-464.
  • 8Kochva E,Viljoen C C,Botes D P. A new type of toxin in the venom of snakes of the genus Atractaspis : (Atractaspidinae) [J ]. Toxicon, 1982,20 (3) : 581-592.
  • 9Seferian A, Simonneau G. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?[J]. Eur Respir Rev, 2013, 22(129): 217-226.
  • 10Buckley MS, Staib RL, Wicks LM. Combination therapy in the management of pulmonary arterial hypertension[J]. Int J Clin Pract Suppl, 2013, 67(179): 13-23.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部